Clinical trials
Phase 1/2 Lymphoma, Large-Cell, Anaplastic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2003 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Terminated | 8 |
| Withdrawn | 3 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Unknown status | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| Fred Hutchinson Cancer Center | 3 |
| National Cancer Institute (NCI) | 3 |
| Bristol-Myers Squibb | 2 |
| City of Hope Medical Center | 2 |
| Columbia University | 2 |
| Mayo Clinic | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Northwestern University | 2 |
| University of Nebraska | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large-Cell, Anaplastic | 43 |
| Immunoblastic Lymphadenopathy | 26 |
| Hodgkin Disease | 22 |
| Lymphoma, Large B-Cell, Diffuse | 22 |
| Lymphoma | 20 |
| Lymphoma, Non-Hodgkin | 19 |
| Lymphoma, Follicular | 18 |
| Lymphoma, Mantle-Cell | 18 |
| Lymphoma, T-Cell, Cutaneous | 18 |
| Mycosis Fungoides | 18 |
Trials
Showing 26 to 43 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.